Imclone systems (IMCL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL)

IMCL 0.159

0.0%

Oct 5 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Sea Otter who wrote (482)	3/20/1999 8:15:00 AM
From: Tim Williams	Read Replies (1) of 2515

Sea Otter, the abstract for the phase II trail of BEC2 can be found at, asco.org Look under 1997 abstracts and search for BEC2. In summary, median survival of 15 BEC2 patients 20.5 months vs 17.9 for reference group of traditionally treated patients.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next